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Illinois, Urbana, IllnoisABSTRACT The clusters of the influenza envelope protein, hemagglutinin, within the plasma membrane are hypothesized to
be enriched with cholesterol and sphingolipids. Here, we directly tested this hypothesis by using high-resolution secondary ion
mass spectrometry to image the distributions of antibody-labeled hemagglutinin and isotope-labeled cholesterol and sphingoli-
pids in the plasma membranes of fibroblast cells that stably express hemagglutinin. We found that the hemagglutinin clusters
were neither enriched with cholesterol nor colocalized with sphingolipid domains. Thus, hemagglutinin clustering and localization
in the plasma membrane is not controlled by cohesive interactions between hemagglutinin and liquid-ordered domains enriched
with cholesterol and sphingolipids, or from specific binding interactions between hemagglutinin, cholesterol, and/or the majority
of sphingolipid species in the plasma membrane.INTRODUCTIONDecades of research have revealed that proteins are non-
randomly distributed within the plasma membranes of
mammalian cells, and this nonrandom protein distribution
is correlated with both normal cell function and disease
(1–7). For example, the clustering of the influenza envelope
protein, hemagglutinin, in the plasma membranes of virus-
infected cells is correlated with influenza virus budding
(4). Although the nonrandom clustering of many proteins,
including influenza hemagglutinin, is sensitive to cellular
cholesterol and sphingolipid levels (1,4,6–15), the mecha-
nisms responsible for this lipid-sensitive protein clustering
are not well understood.
Early studies revealed that the influenza viral envelope
contains high levels of cholesterol and sphingolipids (16),
and is more ordered than the plasma membranes of erythro-
cyte ghosts (17). These results combinedwith the finding that
cholesterol, sphingolipids, and saturated lipids form liquid-
ordered domains in model membranes (18,19) contributed
to the hypothesis that cholesterol and sphingolipids form
ordered plasma membrane domains, which are referred to
as lipid rafts (20–22). Certain membrane proteins, such as
hemagglutinin, are thought to have an affinity for ordered
lipid domains, which causes them to accumulate and clusterSubmitted June 18, 2014, and accepted for publication February 18, 2015.
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0006-3495/15/04/1652/8 $2.00within cholesterol- and sphingolipid-enriched regions in the
plasma membrane (9,20,23). In support of this hypothesis,
hemagglutinin is recovered in a detergent-resistant mem-
brane fraction that is enriched with cholesterol, sphingoli-
pids, and saturated lipids (4,9,18,19,24–27), though later
reports showed that detergent-resistant membranes do not
reflect native membrane composition (28,29). Nonetheless,
the finding that depletion of cellular cholesterol or sphingo-
lipids is detrimental to influenza virus replication (4,30–32)
is consistent with the hypothesized recruitment of hemagglu-
tinin to lipid raft domains.
Recent studies have focused on testing the hypothesis
that hemagglutinin is selectively recruited to ordered mem-
brane domains (8,33–37). However, the local abundance of
cholesterol and sphingolipids can only be inferred from
these biophysical measurements. Though recent lipidome
analyses confirm that the influenza viral envelope is en-
riched with certain sphingolipid species (38) and cholesterol
(39), the question remains, is the site of hemagglutinin clus-
tering in the plasma membrane enriched with cholesterol
and sphingolipids? Such enrichment might result from a pu-
tative affinity of hemagglutinin for the ordered cholesterol-
and sphingolipid-enriched domains that many hypothesize
are present in the plasma membrane. Alternatively direct,
cohesive interactions between hemagglutinin, cholesterol,
and the majority of sphingolipid species in the plasma mem-
brane may enrich the hemagglutinin clusters with choles-
terol and sphingolipids.
In a recent report, we began to address this question by
using fluorescence microscopy to visualize colocalizationhttp://dx.doi.org/10.1016/j.bpj.2015.02.026
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pids and fluorophore-labeled antihemagglutinin Fab frag-
ments in the plasma membranes of mouse fibroblast cells
that stably expressed hemagglutinin (clone 15 cell line)
(40). We found only partial colocalization between the
biosynthetically incorporated fluorescent sphingolipids
and immunolabeled hemagglutinin in the plasma mem-
branes of the clone 15 cells (40). This finding may suggest
hemagglutinin clustering is neither due to the speculated
favorable interactions specific to the ordered cholesterol-
and sphingolipid-enriched domains that many hypothesize
are present in the plasma membrane, nor from presumably
cohesive interactions with sphingolipids. However, the in-
teractions that direct the localization of the hemagglutinin
clusters in the plasma membrane may have been altered
by the fluorophores used to visualize the sphingolipids
(41–44).
We have recently reported the use of a high-resolution
secondary ion mass spectrometry (SIMS) approach for
imaging rare stable isotope-labeled sphingolipids and
cholesterol in the plasma membrane without fluorophore
labels (40,45,46). In this approach, distinct stable isotopes
are metabolically incorporated into the cellular lipid spe-
cies of interest. The resulting stable isotope-labeled lipids
have the same chemical structure as the analogous
unlabeled lipid, so these stable isotopes do not alter the in-
teractions or trafficking of the components that they label.
High-resolution SIMS, which is then performed with a
Cameca NanoSIMS 50 (Cameca, Gennevilliers Cedex,
France), is used to map the lipid-specific isotope enrich-
ments on the surface (top few nanometers) of the cells
with ~100-nm-lateral resolution (40,45,46). Using this
approach, we found sphingolipid domains that were not
enriched with cholesterol in the plasma membranes of
fibroblast cells (40,46).
Here, we assess whether hemagglutinin clusters are
enriched with cholesterol and sphingolipids by using
high-resolution SIMS to simultaneously image 15N-sphin-
golipids, 18O-cholesterol, and immunolabeled hemag-
glutinin in the plasma membrane. To ensure that the
hemagglutinin distributions we observed were not due to
interactions with other virus proteins or virus particle
assembly, we used a mouse fibroblast cell line that stably
expresses hemagglutinin (clone 15 cell line) for this study.
Our data show conclusively that the hemagglutinin clus-
ters were not enriched with cholesterol. Moreover, we
found minimal colocalization between the hemagglutinin
clusters and the sphingolipid domains within the plasma
membrane. Thus, hemagglutinin clustering and local-
ization in the plasma membrane is not controlled by its
putative affinity for ordered domains that are hypotheti-
cally enriched with cholesterol and sphingolipids, or by
direct, cohesive interactions with cholesterol and/or the
majority of the sphingolipid species within the plasma
membrane.MATERIALS AND METHODS
Materials
The Clone 15 cell line was obtained by transfecting NIH 3T3 mouse fibro-
blast cells with a DNA plasmid for hemagglutinin from the 1957 pandemic
Japan strain of influenza. Standard techniques were used to select stably
transfected cells. High-glucose Dulbecco’s modified Eagle’s medium
(DMEM) was prepared by the Cell Media Facility in the School of Chem-
ical Sciences at the University of Illinois. Lipid-reduced fetal bovine serum
(FBS) and calf serum were purchased from Hyclone (Logan, Utah). Fatty
acid-free bovine serum albumin (BSA) and other cell culture materials
were obtained from Sigma (St. Louis, MO). Poly-L-lysine and chemical
preservation reagents were purchased from Electron Microscopy Sciences
(Hatfield, PA). Silicon substrates (5 mm  5 mm) were purchased from
Ted Pella (Redding, CA). The 15N-sphingolipid precursors, 15N-sphingo-
sine, and 15N-sphinganine, were synthesized from 15N-serine (Cambridge
Isotope Laboratories, Tewksbury, MA) using reported methods (47,48).
The 18O-cholesterol was synthesized from i-cholesteryl methyl ether that
was purchased from Sigma and 18O-water that was purchased from Olinax
(Hamilton, Ontario, Canada), as previously reported (49). The hemaggluti-
nin was immunolabeled using a primary antibody (FC 125 antihemaggluti-
nin) developed in mouse and fluorinated colloidal gold (average diameter¼
20 nm) immunolabels that were synthesized as previously reported (50).Cell culture and metabolic labeling
Clone 15 cells were cultured in high-glucose DMEM with 10% calf serum,
104 units/mL penicillin G, and 10 mg/mL streptomycin at 37C and 5%
CO2. To metabolically incorporate nitrogen-15 into the cellular sphingoli-
pids and oxygen-18 into the cellular cholesterol, the cells were maintained
in culture media that contained 3.2 mM of 15N-sphingolipid precursors
(1:1 mol ratio of 15N-sphingosine and 15N-sphinganine) and 20 mMethanol-
amine for 3 days. After the third day, the cells were passaged into DMEM
that was supplemented with 10% (v/v) lipid-reduced FBS, 1% (v/v)
calf serum, 3.2 mM 15N-sphingolipid precursors, 50 mM 18O-cholesterol
(2:5 mass ratio of 18O-cholesterol/fatty acid-free BSA), and 20 mM ethanol-
amine. On the fourth day, the 15N-sphingolipid precursors, 18O-cholesterol,
and ethanolamine were added to produce concentrations of 3.2, 50, and
20 mM, respectively. On the fifth day, the cells were passaged into dishes
containing poly-L-lysine-coated silicon substrates and incubated in the la-
beling media at 37C and 5% CO2 for one additional day. The substrates
with attached cells were immunolabeled and prepared for high-resolution
SIMS analysis as described below. The incorporation of the rare stable iso-
topes into the cellular sphingolipids and cholesterol was assessed by using
the cells that remained adhered to the culture dish. The lipids were extracted
from the cells as previously reported (40,45,51). The nitrogen-15 incorpo-
ration into the cellular sphingomyelin and oxygen-18 incorporation into
the cellular cholesterol were measured with liquid chromatography-mass
spectrometry and gas chromatography-mass spectrometry, respectively, as
reported (45,46). For a separate experiment, another set of Clone 15 cells
were metabolically labeled such that they contained 15N-sphingolipids,
but not 18O-cholesterol, by omitting the 18O-cholesterol from the labeling
media and using calf serum in place of the delipidated FBS.Immunolabeling
The substrates with adherent cells were rinsed twice with phosphate buff-
ered saline (PBS) with calcium (Ca) and magnesium (Mg) and twice with
Hendry’s phosphate buffer (HPB). The cells were fixed for 10 min with
2% paraformaldehyde and 0.05% glutaraldehyde in 0.1 M HPB. After
rinsing the samples twice with HPB and once with PBS without Ca and
Mg, the samples were blocked with immunowash buffer (1% BSA in
PBS without Ca and Mg), incubated with 15 mL of 0.18 mg/mL primaryBiophysical Journal 108(7) 1652–1659
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move unbound antibody. The samples were incubated with 25 mL of freshly
filtered (0.1 mm syringe filter) fluorinated colloidal gold immunolabels
(average diameter ¼ 20 nm (50)), diluted in 0.1 M Na2HPO4 buffer,
pH 7.5) for 30 min, and then were rinsed once with immunowash buffer
and once with HPB. The same protocol was used to prepare the immunola-
bel-free control cells, but the primary antibody was omitted.Cell preservation
The cell samples were preserved as we have previously described
(40,45,46,50). Briefly, the samples were fixed with 4% glutaraldehyde in
HPB for 30 min. After washing twice with HPB and once with water, the
samples were postfixed with freshly filtered (0.22 mm syringe filter) 1%
OsO4 for 15 min, rinsed three times with water, and dried under ambient
conditions.High-resolution SIMS analysis
The samples were coated with 3 nm of iridium (99.95% Ir) using a Cres-
sington 208HR High Resolution Sputter Coater with a rotary-planetary-tilt-
ing stage and Cressington MTM-20 High Resolution Thickness Controller
(Watford, UK). Prior reports establish that this thin metal coating does not
alter the lipid distribution on the cell surface (52) or induce the artifactual
appearance of isotope-enriched domains on the cell surface (40). High-
resolution SIMS was performed on a NanoSIMS 50 instrument (Cameca)
at Lawrence Livermore National Laboratory. To image the distributions
of 18O-cholesterol, 15N-sphingolipids, and the hemagglutinin labeled with
fluorinated colloidal gold immunolabels, the 16O, 18O, 19F, 12C14N,
12C15N, and 13C14N, secondary ions were collected using a static mag-
netic field and electrostatic peak switch at mass 27. Mass table 1 in scans
1, 3, 5, and 7 was 16O, 18O, 19F, 12C14N, and 12C15N; mass table 2
in scans 2, 4, 6, and 8 was 16O, 18O, 12C14N, and 13C14N. A mass
resolving power of ~6700 was used. 15 mm 15 mm regions were analyzed
using a 0.077 pA, 16 keV 133Csþ primary ion beam with a spot size of
~70 nm and a dwell time of 1 ms/pixel. Eight replicate scans of 512 
512 pixels (pixel size ¼ 29 nm by 29 nm) were acquired at each analysis
region, resulting in a primary ion dose of 4.5  1014 ions/cm2. These con-
ditions were used to image the 18O-cholesterol, 15N-sphingolipids, and
the hemagglutinin labeled with fluorinated colloidal gold immunolabels
on two different immunolabeled Clone 15 cells, and one immunolabel-
free clone 15 cell.
To image the sphingolipid and hemagglutinin distributions within large
regions of the plasma membrane, images consisting of 4 replicate scans
of 256  256 pixels (pixel size ¼ 59 nm by 59 nm) were acquired at
15 mm  15 mm regions. Each image was acquired using a 0.264 pA pri-
mary ion beam with a spot size of ~100 nm and a dwell time of 1 ms/pixel.
This corresponds to a primary ion dose of 1.9  1014 ions/cm2. Each anal-
ysis overlapped with the preceding region that was analyzed to facilitate
stitching the resulting SIMS images together in a mosaic. The 12C14N,
12C15N, and 19F secondary ions, and secondary electrons were simulta-
neously collected. These analysis conditions were used to image the
15N-sphingolipids and fluorinated immunolabeled hemagglutinin on five
different cells that were supported on two different substrates.Image analysis
NanoSIMS data were processed with a custom software package
(LIMAGE, L.R. Nittler, Carnegie Institution of Washington, Washington,
DC) run on the PV-Wave platform (Rogue Wave Software, Boulder, CO).
To minimize random variations in the signal intensity, a 3  3-pixel boxcar
smoothing algorithm was applied to the SIMS images, which makes the
value at a given pixel the average ratio of the 3  3 pixel region that is
centered around that pixel. This smoothing resulted in a lateral resolutionBiophysical Journal 108(7) 1652–1659of 87 nm in the 512 by 512 pixel images that were acquired with a
70-nm-diameter analysis beam, and 176 nm in the 256  256 pixel images
that were acquired with a 100-nm-diameter analysis beam. Quantitative
15N- and 18O-enrichment images were constructed by taking the ratio
of the secondary ion counts of the rare to the corresponding abundant
isotope at each pixel (12C15N/12C14N and 18O/16O, respectively);
these ratios minimize variations in the measured isotope enrichment caused
by cell topography and changes in ion count rates (40,45,53,54). The units
of enrichment are based on dividing the measured ratios by the standard nat-
ural abundance ratios (0.00367 and 0.0020052, respectively). This process
produces a quantitative measure of the local abundance of rare isotope-
labeled molecules compared to an unlabeled (natural abundance) cell
(40,45,53,54). A thermal color scale was used to represent the 15N- and
18O-enrichments at each pixel in the SIMS image. The MATLAB Statistics
Toolbox (The MathWorks, Natick, MA) was used to determine the
statistically significant thresholds for 15N-enrichment that signify 15N-
sphingolipid domains, and the statistically significant thresholds for the
19F secondary ion intensities that signify hemagglutinin clusters. The
locations of the 15N-sphingolipid domains were defined with a particle
definition algorithm performed with the aforementioned custom software
package, LIMAGE. In this algorithm, the centers of the 15N-sphingolipid
domains were defined as the pixels where the 15N-enrichment was a local
maximum and at least 2 SD above the mean 15N-enrichment for the nondo-
main membrane regions (55). The edges of the domains were defined by
moving out from the center until the 15N-enrichment dropped below the
Gaussian diameter, which is 13.5% (1/e2) of the 15N-enrichment at the
domain center, or another domain was encountered.
The MATLAB Statistics Toolbox was used to perform two-sample Kol-
mogorov-Smirnov tests for statistically significant differences in the 15N-
sphingolipid domains. The two-sample Kolmogorov-Smirnov test compares
the distance between the empirical cumulative distribution functions of
the data in each set to determine whether the data in the two sets differ
(56). The advantage of this test is that it does not make assumptions about
the distribution of the data (i.e., it does not need to be a normal distribution)
(57). In this work, we compared a data set consisting of the 19F counts
detected within each 15N-sphingolipid domain on a cell to a data set consist-
ing of the 19F counts detected within equally sized nondomain regions
on the same cell. The two-sample Kolmogorov-Smirnov test returns
two outputs: h and p. The value of h is either 0 or 1, whereas the value of
p is between 0 and 1. An output of h ¼ 0 indicates a failure to reject the
null hypothesis that the data in the two sets are from the same distribution,
which means the 19F signal intensities within the two data sets are not
statistically different. In contrast, h ¼ 1 indicates rejection of the null
hypothesis, meaning a statistically significant difference was found between
the 19F signal intensities in the two data sets. The p-value is the probability
of obtaining the observed measurements if the null hypothesis is true.
The null hypothesis is rejected at the 95% confidence level when the p-value
is <0.05.RESULTS
Here, we studied clone 15 cells that stably express hemag-
glutinin instead of influenza-infected cells to ensure that
the hemagglutinin distributions we observed were only
influenced by host cell components, and not by other influ-
enza virus proteins or virus particle assembly. We first
used high-resolution SIMS to image the distributions of
18O-cholesterol, 15N-sphingolipids, and immunolabeled
hemagglutinin in the membranes of clone 15 cells. The cells
were prepared by metabolically incorporating the rare stable
isotopes nitrogen-15 and oxygen-18 into ~90% of the
cellular sphingolipids and 65% of the cellular cholesterol,
respectively. Note that because the clone 15 line we
Hemagglutinin Clusters in the Membrane 1655employed stably expressed influenza hemagglutinin, the
metabolic stable isotope incorporation did not need to be
coordinated with viral protein expression. When metabolic
labeling was complete, we selectively tagged the influenza
hemagglutinin with fluorinated colloidal gold immunola-
bels; these labels produce distinctive 19F secondary ions
that permit their detection with high-resolution SIMS (50).
The cells were chemically fixed with a method that does
not disturb the lipid distribution in the plasma membrane
(40), and coated with a thin layer (3 nm) of iridium that en-
hances the secondary ion signal intensities. It is noteworthy
that this thin metal coating does not induce the lateral
migration of lipids (52) or the artifactual appearance of
isotope-enriched domains on the cell surface (40). Finally,
we used high-resolution SIMS to map the 19F secondary
ions, 15N-enrichment, and 18O-enrichment on the surfaces
of immunolabeled clone 15 cells. Metabolically labeled
clone 15 cells that had not been immunolabeled were also
imaged for comparison.
Regional elevations in 19F secondary ions that are char-
acteristic of immunolabeled hemagglutinin clusters (50)
were detected in the plasma membrane of the immunola-
beled clone 15 cell (Fig. 1). In comparison to the immuno-
labeled clone 15 cell (1,178 19F counts/mm2), relatively
few 19F secondary ions were detected on the immunola-
bel-free clone 15 cell (55 19F counts/mm2), confirming
the specificity of the 19F ion signal for the immunolabels.
Consistent with our previous reports (40,46), local eleva-FIGURE 1 High-resolution SIMS images of metabolically labeled
clone 15 cells with and without hemagglutinin-specific fluorinated immu-
nolabels. Locally high counts of 19F secondary ions that are characteristic
of clusters of immunolabeled hemagglutinin are visible on the immunola-
beled clone 15 cell. In comparison to the immunolabeled clone 15 cell
(1178 19F counts/mm2), relatively few 19F secondary ions (55 19F
counts/mm2) were detected on the clone 15 cell that was not immunolabeled
with hemagglutinin-specific fluorinated colloidal gold affinity labels. Local
elevations in 15N-enrichment that signify regionally high concentrations
of 15N-sphingolipids are visible on both cells. Statistically significant local
elevations in 18O-enrichment, and thus, 18O-cholesterol, within the plasma
membrane were not detected on either cell. To see this figure in color,
go online.tions in 15N-enrichment, and thus 15N-sphingolipids, were
present in the plasma membranes of the immunolabeled
and immunolabel-free clone 15 cells (Fig. 1). Comparison
of the 19F and 15N-enrichment images acquired on the im-
munolabeled clone 15 cell (Fig. 1) suggests little colocaliza-
tion between the hemagglutinin clusters and sphingolipid
domains. The 18O-enrichment images show an absence of
domains enriched with 18O-cholesterol in the plasma mem-
branes of both clone 15 cells (Fig. 1), which is consistent
with our previous finding of a fairly uniform cholesterol
distribution in the plasma membranes of mouse fibroblasts
(46). High-resolution SIMS imaging revealed similar distri-
butions of 15N-sphingolipids, 18O-cholesterol, and immuno-
labeled hemagglutinin in the plasma membrane of the other
immunolabeled clone 15 cell that we analyzed. The absence
of cholesterol-enrichment at the sites of hemagglutinin clus-
tering refutes the hypothesis that hemagglutinin is recruited
to cholesterol-enriched ordered lipid domains in the plasma
membrane. Consequently, hemagglutinin clustering within
the plasma membrane cannot be attributed to a postulated
affinity for ordered cholesterol-rich domains.
The previous results exclude the possibility that hemag-
glutinin is associated with sphingolipid-rich membrane
domains due to its postulated preferential association with
ordered lipid domains that are produced by preferential
cholesterol and sphingolipid packing. However, hemagglu-
tinin might cluster within sphingolipid-enriched domains
if it has an affinity for either the sphingoid backbone, or
for a potentially distinct biophysical environment defined
by the electrostatic properties (i.e., dipole potential and sur-
face potential) within the sphingolipid domains. Therefore,
we next focused on quantitatively assessing the extent of co-
localization between the hemagglutinin clusters and sphin-
golipid domains. In these studies, we used high-resolution
SIMS to image the distributions of these two components
within a large fraction of the dorsal surface of a clone
15 cell. The clone 15 cells had been metabolically labeled
so that ~80% of their sphingolipids contained the nitro-
gen-15 isotope, and the hemagglutinin in their membranes
had been tagged with fluorinated colloidal gold immunola-
bels. Fig. 2 shows the mosaics of the secondary electron,
19F secondary ion, and 15N- enrichment images that were
acquired in parallel with a NanoSIMS 50 instrument. The
mosaic of secondary electron images show which portions
of the analysis area correspond to the surface of the cell,
its perimeter, and the substrate (Fig. 2 a). Numerous
15N-sphingolipid domains and fluorine-rich immunolabeled
hemagglutinin clusters were detected in the plasma mem-
brane of the clone 15 cell (Fig. 2, b and c). However, the
overlay of the 15N-enrichment and 19F secondary ion im-
ages (Fig. 3) shows little colocalization between the hemag-
glutinin clusters and the sphingolipid domains. Quantitative
assessment of the SIMS images confirmed this conclusion,
as only 34 of the 194 hemagglutinin-rich regions
were colocalized with sphingolipid domains, where theBiophysical Journal 108(7) 1652–1659
FIGURE 2 Mosaics of secondary electron, secondary ion, and isotope
enrichment images were constructed from numerous individual SIMS
images that were acquired at 15 mm  15 mm regions on a clone 15 cell.
(A) Mosaic of secondary electron images acquired with the NanoSIMS
instrument shows the cell morphology. (B) Mosaic of 19F secondary ion
images reveals influenza hemagglutinin clusters on the surface of the clone
15 cell. (C) Mosaic of 15N-enrichment images shows the distribution of the
15N-sphingolipids within the plasma membrane. To see this figure in color,
go online.
FIGURE 3 Composite 19F secondary ion and 15N-enrichment images
of a clone 15 cell. The 19F (red) and 15N-enrichment (green) images
that are shown in Fig. 2 were overlaid to facilitate visual assessment of
signal colocalization. To see this figure in color, go online.
1656 Wilson et al.hemagglutinin-rich regions and sphingolipid domains were
defined as statistically significant elevations in the 19F
counts and 15N-enrichment, respectively. Furthermore, a
two-sample Kolmogorov-Smirnov test indicated that the
19F counts in the sphingolipid domains were not statisti-
cally different from the non-domain regions (h ¼ 0, p ¼
0.26). Likewise, little colocalization between the fluorine-
rich immunolabeled hemagglutinin clusters and 15N-sphin-
golipid domains was observed at the regions on the four
other cells that we analyzed in this experiment (17 of 97,
2 of 24, 36 of 328, and 10 of 174 hemagglutinin-rich regions
were colocalized with sphingolipid domains). Note that our
previous report of imaging all membrane lipids in parallel
with immunolabeled hemagglutinin rules out the possibility
that the observed absence of sphingolipid enrichment at the
sites of hemagglutinin clustering is caused by a reduction
in all membrane lipids at these sites (50). Therefore, we
conclude that hemagglutinin does not preferentially localizeBiophysical Journal 108(7) 1652–1659within sphingolipid domains in the plasma membranes of
fibroblasts cells that stably express hemagglutinin. Conse-
quently, hemagglutinin clustering in the plasma membrane
does not appear to be induced by favorable interactions be-
tween hemagglutinin and the majority of the sphingolipid
species in the plasma membrane, or from the recruitment
of hemagglutinin to biophysically distinct sphingolipid-
rich domains.DISCUSSION
Specific steps in influenza virus replication have been asso-
ciated with distinct hemagglutinin organizations in the host
cell’s plasma membrane. For example, late in the infection
cycle, hemagglutinin accumulation in the plasma membrane
activates the Ras/MEK/ERK signaling cascade that is
required for nuclear export of the viral ribonucleoprotein
complexes (58). Additionally, the release of infectious influ-
enza viruses from the host cell is preceded by the formation
of large clusters of hemagglutinin within the plasma mem-
brane (59). This hemagglutinin clustering is often attributed
to its recruitment to ordered membrane domains that are
enriched with sphingolipids and cholesterol (39,60). In
contrast to this hypothesis, here we have found that in the
absence of other viral components, the hemagglutinin clus-
ters were not enriched with cholesterol or colocalized with
sphingolipid domains in the plasma membrane. This lack
of colocalization between hemagglutinin and sphingolipids
is consistent with our previous results of imaging fluorescent
sphingolipids in parallel with fluorophore-labeled Fab frag-
ments in living cells (40). This consistency rules out the pos-
sibilities that the cell fixation or secondary antibodies used
for high-resolution SIMS imaging altered the findings re-
ported herein. Thus, we reject the long-standing hypothesis
that hemagglutinin has an affinity for liquid-ordered do-
mains that are putatively produced by preferential choles-
terol and sphingolipid packing. Based on our findings, we
also conclude that cohesive molecular interactions between
Hemagglutinin Clusters in the Membrane 1657hemagglutinin, cholesterol, and/or all sphingolipid species,
are not sufficient to recruit these components to distinct
membrane domains.
Our conclusion that hemagglutinin’s postulated affinity
for an ordered environment produced by preferential choles-
terol and sphingolipid packing is not responsible for its
membrane organization is consistent with recent studies
that probed the biophysical properties of the plasma mem-
brane domain where hemagglutinin clusters reside. For
example, magic angle spinning NMR analysis showed pri-
marily disordered lipid domains in intact influenza viruses
at physiological temperatures (33). Likewise, fluorescence
microscopy revealed that hemagglutinin predominantly re-
sides within liquid disordered domains in synthetic vesicles
or vesicles derived from the plasma membrane (34). Though
hemagglutinin organization in cellular membranes is often
found to be cholesterol sensitive (8,35–37), biophysical be-
haviors that are inconsistent with hemagglutinin localization
within cholesterol-rich ordered membrane domains have
also been reported (8,35,36). Such results suggest that lipid
phase behavior is not the sole determinant of hemagglutinin
clustering in the plasma membrane.
In light of these findings, what mechanisms might be
responsible for the reported enrichment of the influenza viral
envelope with cholesterol and sphingolipids (16,38,39)?
Becausewemetabolically labeled and visualized all sphingo-
lipid species in this study, we cannot rule out the possibility
that hemagglutinin preferentially associates with a small
number of less abundant sphingolipid subspecies within the
plasma membrane. Favorable interactions with these distinct
sphingolipid subspecies might arise due to specific inter-
actions between hemagglutinin and certain glycosylated
headgroups or distinctive fatty acid side chains. Likewise,
this work does not exclude the possibility that the affinity of
hemagglutinin for cholesterol and sphingolipids ismodulated
by other influenza virus components. Moreover, the finding
that the inhibition of cellular phospholipase A2 (PLA2) re-
duces influenza virus production (61) could suggest that the
elevated fractions of cholesterol and sphingolipids found in
the influenza viral envelope reflect a depletion of phosphati-
dylcholine due to its degradation by PLA2 at the site of virus
budding. Future work is required to assess these possibilities.
Our finding that hemagglutinin clustering is not induced
by its affinity for cholesterol or sphingolipids is consistent
with a recent report that the clustering of hemagglutinin in
the plasma membranes of cells that stably express hemag-
glutinin is mediated by actin (62). Interestingly, although
sphingolipids and cholesterol are primarily known for their
roles as structural components in membranes, one sphingo-
lipid, ceramide, and cholesterol are also involved in modu-
lating the actin cytoskeleton. Specifically, ceramide is a
signaling molecule that initiates cytoskeletal reorganization
via activation of protein phosphorylation (63–65), whereas
cholesterol depletion induces changes in cytoskeletal orga-
nization via an unknown mechanism (66–68). This suggeststhat sphingolipids and cholesterol may indirectly modulate
hemagglutinin clustering through their effects on actin orga-
nization, and not by directly interacting with hemagglutinin.
Efforts that probe the effects of cholesterol and sphingoli-
pids on the cytoskeletal rearrangements required for virus
budding are needed to explore this possibility.AUTHOR CONTRIBUTIONS
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